VRNA logo

Verona Pharma (VRNA)

Profile

Full Name

Verona Pharma plc

Ticker Symbol

VRNA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United Kingdom

IPO

April 28, 2017

Indexes

Not included

Website

http://www.veronapharma.com

Employees

209

Key Details

Price

$57.81(+0.17%)

Market cap

$4.91B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$42.28M

Annual EPS

-$2.16(-200.00% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$57.81
VRNA price is $57.81

30-Day Relative Volume

0.62
VRNA 30-day relative volume is 0.62

Price Performance

Price Most recent change

+0.17%
VRNA price was up +0.17% on Apr 14, 2025

Price YTD change

+24.48%
VRNA price is up +24.48% since January 1st

Price 1-year change

+265.89%
VRNA price is up +265.89% year-on-year

Price 3-year change

+1323.89%
VRNA price is up +1323.89% over the past 3 years

Price Range

Price All-time high

$70.40
VRNA price is currently -17.88% below its historical high of $70.40

Price 3-year low

$3.41
VRNA price is currently +1596.30% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$4.91B
VRNA market capitalization is $4.91 billion

Market cap 3-year change

+1905.31%
VRNA market capitalization is up +1905.31% over the past 3 years

Market cap All-time high

$5.94B
VRNA market capitalization is currently -17.24% below its historical high of $5.94 billion

Market cap sector rank

89.06%
VRNA market capitalization is higher than 89.06% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+5.06%
VRNA shares outstanding is up +5.06% year-on-year

Shares Outstanding 3-Year Change

+40.83%
VRNA shares outstanding is up +40.83% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.99
VRNA beta is 0.99

200-day SMA

$40.82
VRNA price is currently +41.63% above its 200-day simple moving average

50-day SMA

$62.61
VRNA price is currently -7.67% below its 50-day simple moving average

RSI

45.78
VRNA 14-day relative strength index is 45.78

Volume

0.62
VRNA 30-day relative volume is 0.62

ATR

$4.28
VRNA average true range is $4.28

10-day Historical Volatility

87.48%
VRNA 10-day historical volatility is 87.48%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$42.28M
VRNA annual revenue is $42.28 million

Revenue Analysts estimate

$243.22M
VRNA annual revenue is currently -82.62% lower than the consensus analysts' forecast

Revenue 1-year change

-
VRNA annual revenue 1-year change is unknown

Revenue Sector rank

45.02%
VRNA annual revenue is higher than 45.02% of companies in Healthcare sector

EPS

EPS

-$2.16
VRNA annual earnings per share is -$2.16

EPS Analysts estimate

-$0.04
VRNA annual earnings per share is currently +5660.00% higher than the consensus analysts' forecast

EPS 1-year change

-200%
VRNA annual earnings per share is down -200% year-on-year

EPS Sector rank

36.97%
VRNA annual earnings per share is higher than 36.97% of companies in Healthcare sector

Profit

Gross profit

$39.70M
VRNA annual gross profit is $39.70 million

Gross margin

93.89%
VRNA annual gross profit margin is 93.89%

Operating profit

-$151.03M
VRNA annual operating income is -$151.03 million

Operating margin

-357.22%
VRNA annual operating profit margin is -357.22%

Net income

-$173.42M
VRNA annual net profit is -$173.42 million

Net margin

-410.18%
VRNA annual net profit margin is -410.18%

Expenses

Total expenses

$193.31M
VRNA annual total expenses is $193.31 million

Operating expenses

$190.72M
VRNA annual total operating expenses is $190.72 million

Cost of goods sold

$2.58M
VRNA annual cost of goods sold is $2.58 million

Selling, general & administrative expenses

$149.75M
VRNA annual SGA is $149.75 million

Depreciation and amortization

$1.06M
VRNA annual depreciation & amortization is $1.06 million

Interest expense

$23.54M
VRNA annual interest expense is $23.54 million

Income tax

$10.29M
VRNA annual income tax is $10.29 million

EBIT & EBITDA

EBIT

-$139.59M
VRNA annual earnings before interest & taxes is -$139.59 million

EBITDA

-$138.53M
VRNA annual EBITDA is -$138.53 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$474.24M
VRNA annual total assets is $474.24 million

Non current assets

$20.67M
VRNA annual long term assets is $20.67 million

Current assets

$453.57M
VRNA annual total current assets is $453.57 million

Cash and cash equivalents

$399.76M
VRNA annual cash & cash equivalents is $399.76 million

Accounts receivable

$31.50M
VRNA annual accounts receivable is $31.50 million

Inventory

$6.25M
VRNA annual inventory is $6.25 million

Liabilities

Total liabilities

$269.68M
VRNA annual total liabilities is $269.68 million

Long term liabilities

$227.00M
VRNA annual total long term liabilities is $227.00 million

Current liabilities

$42.68M
VRNA annual total current liabilities is $42.68 million

Accounts payable

$11.27M
VRNA annual accounts payable is $11.27 million

Debt

Total debt

$122.70M
VRNA annual total debt is $122.70 million

Total debt 1-year change

+139.05%
VRNA annual total debt is up +139.05% year-on-year

Long term debt

$121.58M
VRNA annual long term debt is $121.58 million

Short term debt

$1.12M
VRNA annual short term debt is $1.12 million

Equity & Capital

Shareholders equity

$204.56M
VRNA annual stockholders equity is $204.56 million

Book value

$204.56M
VRNA annual book value is $204.56 million

Retained earnings

-$562.40M
VRNA annual retained earnings is -$562.40 million

Working capital

$410.89M
VRNA annual working capital is $410.89 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$122.20M
VRNA annual cash flow from operations is -$122.20 million

Cash from operations 1-year change

-143.33%
VRNA annual cash flow from operations is down -143.33% year-on-year

Cash from investing

-$580.00K
VRNA annual cash flow from investing activities is -$580.00 thousand

Cash from investing 1-year change

-100%
VRNA annual cash flow from investing activities is down -100% year-on-year

Cash from financing

$250.78M
VRNA annual cash flow from financing activities is $250.78 million

Cash from financing 1-year change

+170.04%
VRNA annual cash flow from financing activities is up +170.04% year-on-year

CAPEX

CAPEX

$580.00K
VRNA annual capital expenditures is $580.00 thousand

CAPEX 1-year change

-
VRNA annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$122.78M
VRNA annual free cash flow is -$122.78 million

Free cash flow 1-year change

-144.48%
VRNA annual free cash flow is down -144.48% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

93.89%
VRNA annual gross profit margin is 93.89%

Operating margin

-357.22%
VRNA annual operating profit margin is -357.22%

Net margin

-410.18%
VRNA annual net profit margin is -410.18%

ROA & ROE

ROA

-44.33%
VRNA annual return on assets is -44.33%

ROE

-76.42%
VRNA annual return on equity is -76.42%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
VRNA price to earnings ratio value is unknown

PE ratio Sector rank

-
VRNA price to earnings ratio is unknown

PB Ratio

PB ratio

24.03
VRNA price to book ratio is 24.03

PB ratio Sector rank

97.28%
VRNA price to book ratio is higher than 97.28% of companies in Healthcare sector

PS Ratio

PS ratio

116.25
VRNA price to sales ratio is 116.25

PS ratio Sector rank

95.38%
VRNA price to sales ratio is higher than 95.38% of companies in Healthcare sector

Enterprise value

Enterprise value

$4.64B
VRNA enterprise value is $4.64 billion

Enterprise value Sector rank

87.36%
VRNA enterprise value is higher than 87.36% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-33.48
VRNA EV/EBITDA is -33.48

EV/EBITDA Sector rank

4.17%
VRNA EV/EBITDA is higher than 4.17% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

10.63
VRNA annual current ratio is 10.63

Quick ratio

10.48
VRNA annual quick ratio is 10.48

Leverage

Debt to equity

0.59
VRNA annual debt to equity ratio is 0.59

Interest coverage ratio

-5.93
VRNA annual interest coverage ratio is -5.93

Risk & Stability

Piotroski F-Score

-
VRNA piotroski f-score value is unknown

Altman Z-Score

9.43
VRNA altman z-score is 9.43

Analyst ratings

Recent major analysts updates

Feb 28, 25 Wells Fargo
Overweight
Feb 28, 25 HC Wainwright & Co.
Buy
Feb 12, 25 Canaccord Genuity
Buy
Jan 21, 25 HC Wainwright & Co.
Buy
Jan 10, 25 Roth MKM
Buy
Jan 8, 25 Wells Fargo
Overweight
Jan 8, 25 Truist Securities
Buy
Nov 5, 24 Wells Fargo
Overweight
Nov 5, 24 HC Wainwright & Co.
Buy
Nov 5, 24 Canaccord Genuity
Buy

Institutional Ownership

Similar stocks

KRYS logo
Krystal Biotech (KRYS)
ADMA logo
ADMA Biologics (ADMA)
NUVL logo
Nuvalent (NUVL)
AXSM logo
Axsome Therapeutics (AXSM)
GRFS logo
Grifols SA (GRFS)
CYTK logo
Cytokinetics Incorporated (CYTK)
GKOS logo
Glaukos (GKOS)
OPCH logo
Option Care Health (OPCH)
IONS logo
Ionis Pharmaceuticals (IONS)
  • What is the ticker symbol for Verona Pharma?
  • Does Verona Pharma pay dividends?
  • What sector is Verona Pharma in?
  • What industry is Verona Pharma in?
  • What country is Verona Pharma based in?
  • When did Verona Pharma go public?
  • Is Verona Pharma in the S&P 500?
  • Is Verona Pharma in the NASDAQ 100?
  • Is Verona Pharma in the Dow Jones?
  • When was Verona Pharma's last earnings report?
  • When does Verona Pharma report earnings?
  • Should I buy Verona Pharma stock now?

What is the ticker symbol for Verona Pharma?

The ticker symbol for Verona Pharma is NASDAQ:VRNA

Does Verona Pharma pay dividends?

No, Verona Pharma does not pay dividends

What sector is Verona Pharma in?

Verona Pharma is in the Healthcare sector

What industry is Verona Pharma in?

Verona Pharma is in the Biotechnology industry

What country is Verona Pharma based in?

Verona Pharma is headquartered in United Kingdom

When did Verona Pharma go public?

Verona Pharma's initial public offering (IPO) was on April 28, 2017

Is Verona Pharma in the S&P 500?

No, Verona Pharma is not included in the S&P 500 index

Is Verona Pharma in the NASDAQ 100?

No, Verona Pharma is not included in the NASDAQ 100 index

Is Verona Pharma in the Dow Jones?

No, Verona Pharma is not included in the Dow Jones index

When was Verona Pharma's last earnings report?

Verona Pharma's most recent earnings report was on Feb 27, 2025

When does Verona Pharma report earnings?

The next expected earnings date for Verona Pharma is May 9, 2025

Should I buy Verona Pharma stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page